Literature DB >> 22608690

Serum white blood cell count and differential do not have a role in the diagnosis of periprosthetic joint infection.

Nader Toossi1, Bahar Adeli, Mohammad R Rasouli, Ronald Huang, Javad Parvizi.   

Abstract

Serum white blood cell (WBC) count and neutrophil differential are frequently ordered during preoperative workup of suspected cases of periprosthetic joint infection (PJI). However, their roles in diagnosis of PJI have remained unclear despite previous studies. In this study, preoperative serum WBC and neutrophil percentages were retrieved from hospital charts. The diagnostic cutoff point determined by receiver operating characteristic curve analysis was 7800 cells/μL with 55% sensitivity and 66% specificity for WBC count, whereas the cutoff value for neutrophil percentage was 68% with 52% sensitivity and 75% specificity. Our study confirms the long-held belief that serum WBC count and differential has minimal role in routine workup of patients with suspected PJI.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22608690     DOI: 10.1016/j.arth.2012.03.021

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  11 in total

1.  Postoperative antibiotic prophylaxis in total hip and knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Patrick Thornley; Nathan Evaniew; Michael Riediger; Mitchell Winemaker; Mohit Bhandari; Michelle Ghert
Journal:  CMAJ Open       Date:  2015-07-17

2.  Excluding infections in arthroplasty using leucocyte esterase test.

Authors:  Daniel Guenther; Thomas Kokenge; Oliver Jacobs; Mohamed Omar; Christian Krettek; Thorsten Gehrke; Daniel Kendoff; Carl Haasper
Journal:  Int Orthop       Date:  2014-07-16       Impact factor: 3.075

3.  Painful knee arthroplasty: current practice.

Authors:  Umberto Cottino; Federica Rosso; Antonio Pastrone; Federico Dettoni; Roberto Rossi; Matteo Bruzzone
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

4.  Lipopolysaccharide-binding protein: a valuable biomarker in the differentiation between periprosthetic joint infection and aseptic loosening?

Authors:  Max J Friedrich; Thomas M Randau; Matthias D Wimmer; Ben Reichert; Dominik Kuberra; Birgit Stoffel-Wagner; Dieter C Wirtz; Sascha Gravius
Journal:  Int Orthop       Date:  2014-05-15       Impact factor: 3.075

5.  Normal CRP and WBC values in total hip arthroplasty (THA) with signs of loosening. Do we need a joint aspiration?

Authors:  Erik Schiffner; David Latz; Simon Thelen; Jan P Grassmann; Alfred Karbowski; Joachim Windolf; Johannes Schneppendahl; Pascal Jungbluth
Journal:  J Clin Orthop Trauma       Date:  2018-09-26

6.  Management of Resistant, Atypical and Culture-negative Periprosthetic Joint Infections after Hip and Knee Arthroplasty.

Authors:  Alexander S McLawhorn; Danyal H Nawabi; Amar S Ranawat
Journal:  Open Orthop J       Date:  2016-11-30

7.  Periprosthetic joint infection: Current concept.

Authors:  Vinay K Aggarwal; Mohammad R Rasouli; Javad Parvizi
Journal:  Indian J Orthop       Date:  2013-01       Impact factor: 1.251

8.  Characteristics and significance of fever during 4 weeks after primary total knee arthroplasty.

Authors:  Yoshinori Ishii; Hideo Noguchi; Mitsuhiro Takeda; Junko Sato; Satoshi Takayama; Shin-ichi Toyabe
Journal:  Arch Orthop Trauma Surg       Date:  2014-02-13       Impact factor: 3.067

9.  Interleukin-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening.

Authors:  Thomas M Randau; Max J Friedrich; Matthias D Wimmer; Ben Reichert; Dominik Kuberra; Birgit Stoffel-Wagner; Andreas Limmer; Dieter C Wirtz; Sascha Gravius
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

Review 10.  Identification of periprosthetic joint infection after total hip arthroplasty.

Authors:  Kyung-Jae Lee; Stuart B Goodman
Journal:  J Orthop Translat       Date:  2014-11-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.